SilicoGenesis

SilicoGenesis

Biotechnology Research

Leuven, Flemish Region 476 followers

Develop better antibodies faster with our AI-enabled in silico antibody engineering platform.

About us

SilicoGenesis is revolutionizing the field of antibody and biologic design, discovery, and optimization, positioning itself as a leader in the industry. Our cutting-edge expertise and advanced technologies empower pharmaceutical and biotech companies to expedite and scale up the discovery and optimization of antibody lead molecules. Through our state-of-the-art AI/ML algorithms, in-silico pipelines, and collaborative expert team, we rapidly develop innovative therapeutic lead molecules. Our comprehensive suite of solutions in the drug discovery pipeline encompasses: * Precise 3D modeling of protein structures. * Accurate prediction of paratope and epitope residues. * Thorough characterization and modeling of protein-protein interactions. * Enhancement of binding affinity and mutagenesis studies. * Cross-species reactivity analysis. * Expert humanization of antibody candidates. * Rigorous assessment of developability liabilities. SilicoGenesis has established a strong track record of successful collaborations with numerous pharmaceutical companies, biotech firms, and academic institutions across diverse projects. We are committed to supporting your specific needs and objectives. To learn more about our transformative capabilities, please visit our website at www.silicogenesis.com.

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Leuven, Flemish Region
Type
Partnership
Founded
2021
Specialties
Bioinformatics, Computational Biology, Machine Learning, Protein Biochemistry, Antibody Engineering, Artificial Intelligence, Structural Biology, Drug Discovery, Protein Engineering, and Nanobody Engineering

Locations

Employees at SilicoGenesis

Updates

Similar pages